Skip to main content
Filing year 2023

ALZHEIMER'S DRUG DISCOVERY FOUNDATION

New York, New York·EIN 20-1082179·NTEE V36 · Social Science·3
Total revenue
$37.7M
Total assets
$324.2M
Total expenses
$61.9M
Reported officers
30
Mission

ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.

Executive compensation, broken down

Form 990 · Schedule J · 8 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
Founding Exec. Dir. & Chief Sci. Off.
officer (unspecified)
$665k
$746k
Executive Director, Drug Dev.
$467k
$524k
CFO and Head of Mission
$391k
$439k
Chief External Affairs
highest compensated employee
$372k
$417k
Head of Search and Evaluation
highest compensated employee
$350k
$393k
Attorney, Mission-related Investments
highest compensated employee
$230k
$258k
Director, Search & Evaluation
highest compensated employee
$214k
$240k

Teal figures restate each filed amount in 2026 dollars.

Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 22 unpaid individuals.

Browse compensation in Social Science

Sector benchmark

What Social Science executives earn

Comparable social science organizations nationwide pay their highest-earning executive a median of $120,010.

25th percentile
$55k
Median
$120,010
75th percentile
$208k
90th percentile
$415k

These are social science sector-wide figures, not this organization's reported pay. Based on 409 organizations across 409 filings (2021 – 2024).

See full Social Science compensation data
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.